PanGen Biotech Inc. (KOSDAQ:222110)
South Korea
· Delayed Price · Currency is KRW 6,010.00
-190.00 (-3.06%)
At close: Apr 28, 2026
PanGen Biotech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 2,051 | 943.69 | -4,489 | -4,494 | -3,310 | Upgrade
|
| Depreciation & Amortization | 1,465 | 1,468 | 1,597 | 1,603 | 1,532 | Upgrade
|
| Loss (Gain) From Sale of Assets | -17.01 | -13.94 | -15.15 | 0.24 | 0.67 | Upgrade
|
| Stock-Based Compensation | - | - | 12.18 | 236.78 | 224.6 | Upgrade
|
| Provision & Write-off of Bad Debts | -252.64 | 148.57 | 148.57 | - | - | Upgrade
|
| Other Operating Activities | -78.92 | 658.72 | 1,052 | 642.78 | 693.36 | Upgrade
|
| Change in Accounts Receivable | 1,646 | -746.76 | -1,659 | 386.46 | -552.25 | Upgrade
|
| Change in Inventory | -1,228 | 930.24 | -752.12 | -2,257 | -608.69 | Upgrade
|
| Change in Accounts Payable | -265.49 | 124.51 | 43.34 | -126.43 | 85.41 | Upgrade
|
| Change in Other Net Operating Assets | -3,130 | -526.46 | 612.11 | 505.41 | -1,389 | Upgrade
|
| Operating Cash Flow | 189.81 | 2,987 | -3,451 | -3,503 | -3,324 | Upgrade
|
| Operating Cash Flow Growth | -93.64% | - | - | - | - | Upgrade
|
| Capital Expenditures | -562.81 | -360.06 | -422.13 | -728.05 | -1,425 | Upgrade
|
| Sale of Property, Plant & Equipment | 17.09 | 150 | 15.2 | 34.62 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -174.61 | -14.07 | -62.86 | -5.8 | -49.29 | Upgrade
|
| Investment in Securities | 250.3 | -10,077 | -50 | 15,048 | -4,451 | Upgrade
|
| Other Investing Activities | -342.16 | -35.8 | -51.34 | -119.4 | -100.22 | Upgrade
|
| Investing Cash Flow | -812.18 | -10,337 | -571.13 | 14,229 | -6,026 | Upgrade
|
| Short-Term Debt Issued | - | 980 | 986 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | 3,204 | 60.19 | 68.91 | Upgrade
|
| Total Debt Issued | - | 980 | 4,190 | 60.19 | 68.91 | Upgrade
|
| Short-Term Debt Repaid | - | -980 | -986 | - | - | Upgrade
|
| Long-Term Debt Repaid | -1.84 | -516.88 | -1.56 | -18,829 | -1.04 | Upgrade
|
| Total Debt Repaid | -1.84 | -1,497 | -987.56 | -18,829 | -1.04 | Upgrade
|
| Net Debt Issued (Repaid) | -1.84 | -516.88 | 3,202 | -18,769 | 67.88 | Upgrade
|
| Issuance of Common Stock | 2,967 | 9,261 | - | 33.68 | 10,051 | Upgrade
|
| Other Financing Activities | -2.69 | -9.43 | -27.34 | -0.51 | -6.16 | Upgrade
|
| Financing Cash Flow | 2,963 | 8,735 | 3,175 | -18,736 | 10,112 | Upgrade
|
| Foreign Exchange Rate Adjustments | -14.86 | - | - | - | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | -0 | -0 | Upgrade
|
| Net Cash Flow | 2,326 | 1,385 | -847.06 | -8,009 | 762.18 | Upgrade
|
| Free Cash Flow | -373 | 2,627 | -3,873 | -4,231 | -4,749 | Upgrade
|
| Free Cash Flow Margin | -2.78% | 17.90% | -52.94% | -65.08% | -59.85% | Upgrade
|
| Free Cash Flow Per Share | -26.56 | 228.26 | -362.70 | -396.34 | -464.83 | Upgrade
|
| Cash Interest Paid | 0.12 | 1.15 | 2.29 | 0.53 | 0.53 | Upgrade
|
| Cash Income Tax Paid | 60.91 | 69.84 | -39.51 | 79.39 | 34.79 | Upgrade
|
| Levered Free Cash Flow | 1,280 | 228.45 | -1,012 | -2,828 | -4,331 | Upgrade
|
| Unlevered Free Cash Flow | 1,372 | 429.76 | -874.1 | -2,748 | -4,148 | Upgrade
|
| Change in Working Capital | -2,978 | -218.46 | -1,756 | -1,492 | -2,464 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.